Search

everythinglearnresearchcommunity

for

Search:↓

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Proper education can prevent traction alopecia in women of color.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Early treatment helps stop hair loss in women of color.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Methotrexate side effects vary by race and sex.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.